特殊酵素 – 市場シェア分析、業界動向と統計、成長予測 2025-2030年

特殊酵素市場は、原料（植物、微生物、動物）、形態（液体、乾燥）、酵素の種類（炭水化物分解酵素、プロテアーゼ、リパーゼ、その他）、用途（食品および飲料、医薬品、動物飼料、その他）、および地域（北米、ヨーロッパ、アジア太平洋、南米、中東およびアフリカ）によって区分されています。

特殊酵素市場は2025年に65億9,000万米ドルに達し、2030年までに100億9,000万米ドルに拡大し、年平均成長率（CAGR）8.89%で成長すると予測されています。医薬品合成における生体触媒の急速な採用、環境に優しい工業プロセスへの需要の高まり、酵素ベースの医薬品のより広範な治療薬承認が、成長軌道を牽引しています。AI誘導酵素エンジニアリングへの投資により、開発サイクルは数年から数ヶ月に短縮され、より迅速な商業化が促進され、コスト障壁が低減しました。これらの進歩により、メーカーはコスト効率を維持しながら、進化する業界の需要に対応できるようになりました。より環境に優しい化学物質を優遇する規制上のインセンティブと、天然成分配合を好む消費者の嗜好が相まって、メーカーは組み換え酵素や植物由来酵素へと向かっています。セルロース変換効率を2倍にすることができるCelOCE金属酵素のようなブレークスルーは、バイオ燃料やその他の資源集約型産業における酵素イノベーションの変革の可能性を浮き彫りにしています。このようなイノベーションにより、さまざまなアプリケーションにわたって持続可能性と運用効率が大幅に向上すると期待されています。

Specialty Enzymes Market Analysis

The specialty enzymes market size stands at USD 6.59 billion in 2025 and is projected to advance to USD 10.09 billion by 2030, reflecting an 8.89% CAGR. Rapid adoption of biocatalysts in pharmaceutical synthesis, a rising demand for eco-friendly industrial processing, and broader therapeutic approvals for enzyme-based medicines drive the growth trajectory. Investments in AI-guided enzyme engineering have shortened development cycles from years to months, facilitating quicker commercialization and reducing cost barriers. These advancements are enabling manufacturers to meet evolving industry demands while maintaining cost efficiency. Regulatory incentives favoring greener chemistries, combined with consumer preferences for natural formulations, are pushing manufacturers towards recombinant and plant-derived enzymes. Breakthroughs like the CelOCE metalloenzyme, which can double cellulose conversion efficiency, highlight the transformative potential of enzyme innovation in biofuels and other resource-intensive industries. Such innovations are expected to significantly enhance sustainability and operational efficiency across various applications.

Global Specialty Enzymes Market Trends and Insights

Increasing Adoption of Eco-friendly Biocatalysts in Pharmaceutical Manufacturing

Pharmaceutical manufacturers are adopting biocatalysts instead of traditional chemical catalysts to comply with environmental regulations and optimize manufacturing costs. The Food and Drug Administration (FDA)’s regulatory review periods for biologics, including POMBILITI and EPKINLY in 2025, indicate streamlined approval processes for enzyme-based therapeutics . Engineered enzymes enable the production of chiral pharmaceutical intermediates with improved selectivity and reduced waste compared to traditional methods. Computational design tools have shortened enzyme development cycles, enabling pharmaceutical companies to develop biocatalysts for specific drug synthesis routes more efficiently. This transition is significant in biologics production, where enzyme specificity reduces purification requirements. The applications have expanded to enzyme-based drug delivery systems and therapeutic enzymes for genetic disorders, creating new opportunities for specialty enzyme manufacturers.

Government Support Drives Market Growth Through Policy and Funding

Government initiatives are accelerating the growth of the specialty enzymes market through policy frameworks and direct funding that support research, commercialization, and industrial adoption. Governments provide grants, tax incentives, and public-private partnership (PPP) programs to support research and development in enzymatic innovations across biopharmaceuticals, diagnostics, food processing, and industrial biocatalysis sectors. India’s BioE3 policy represents a major government intervention in biotechnology, with an allocation of INR 9,197 crore (USD 1.1 billion) to establish biomanufacturing hubs for bio-based chemicals and enzymes. The policy aims to achieve a USD 300 billion bioeconomy by 2030, identifying enzymes as essential components across six areas, including precision biotherapeutics and climate-resilient agriculture . China’s updated food safety regulatory system has created opportunities for enzyme manufacturers through mandatory registration procedures that benefit established companies with proven safety records . The European Union’s pre-market approval requirements for food enzymes have standardized safety assessments, reducing market entry barriers for compliant manufacturers.

High Production Cost for Customised Enzymes

The complex processes involved in designing, engineering, and scaling up tailored enzymes require substantial investment in advanced technologies, skilled labor, and quality control measures. The need for specialized raw materials and stringent regulatory compliance increases production costs. Customizing enzymes for specific industrial processes demands extensive research and development investments, with development timelines typically exceeding 2-3 years before commercial viability. Small and medium-sized biotechnology companies encounter significant challenges in scaling production from laboratory to commercial quantities. The required fermentation infrastructure demands substantial capital investment and specialized expertise. The pricing difference between industrial and pharmaceutical enzymes reflects their distinct value propositions, with pharmaceutical proteins priced at thousands of dollars per kilogram compared to tens of dollars for industrial applications. Manufacturing economics are impacted by the requirement for specialized purification processes and quality control systems that comply with regulatory standards for different end-use applications.

Other drivers and restraints analyzed in the detailed report include:

• Advancement in Enzyme Engineering and Directed Evolution
• Demand from Cosmetic and Dermatology Sectors for Enzymatic Peels
• Short Shelf Life and Stability Challenges

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Microbial sources hold a 68.84% market share in 2024, due to the scalability and cost advantages of recombinant DNA technology for enzyme production. Plant-derived enzymes are growing at 9.97% CAGR (2025-2030), driven by consumer demand for natural ingredients and sustainability requirements in food and cosmetic applications. Animal-derived enzymes experience declining demand due to ethical concerns and regulatory restrictions, especially in European markets where alternative sources are increasingly required.

The high market share of microbial enzymes results from their production in controlled fermentation environments, ensuring consistent quality and reduced contamination risks compared to plant or animal tissue extraction. Microbial production systems leverage advances in synthetic biology to develop production strains with improved enzyme secretion and minimized by-product formation. The growth in plant sources is supported by new enzyme extraction methods from agricultural waste, which create circular economy opportunities and lower raw material costs.

Liquid formulations dominate the market with a 57.23% share in 2024 and are projected to grow at a CAGR of 10.47% through 2030, driven by their superior performance characteristics and application versatility. Dry enzyme formulations maintain their position in specialized applications where extended shelf life and reduced shipping costs are essential, particularly in animal feed and industrial cleaning sectors. The market preference for liquid formulations stems from their immediate bioavailability and seamless integration into manufacturing processes without dissolution requirements. Recent advances in stabilization technologies have improved the shelf life of liquid enzymes, addressing a key historical limitation compared to dry formulations.

Non-aqueous liquid systems are increasing in adoption for applications that require better substrate solubility and reduced feedback inhibition. Concentrated liquid formulations offer reduced storage and transportation costs while maintaining enzyme activity. Dry formulations continue to improve through advanced spray-drying and freeze-drying techniques that maintain enzyme structure and activity during dehydration.

The Specialty Enzymes Market is Segmented by Source (Plant, Microbial, and Animal), by Form (Liquid, and Dry), by Enzyme Type (Carbohydrases, Proteases, Lipases, and Others), by Application (Food and Beverages, Pharmaceutical, Animal Feed, and Others), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

In 2024, North America clinched a commanding 33.22% share of the specialty enzymes market, bolstered by its robust pharmaceutical research and development landscape and efficient regulatory pathways that expedite enzyme-based drug approvals. Leading universities in the region spearhead AI-driven enzyme design, propelling domestic innovation. Furthermore, tax incentives championing sustainable manufacturing have amplified enzyme utilization across various industrial processes, solidifying North America’s preeminence. The region’s strong focus on technological advancements and partnerships between academia and industry further strengthens its competitive edge in the global market.

Asia-Pacific, on the other hand, is set to outpace others with a projected 10.04% CAGR. Supportive policies and inherent cost advantages underpin this growth. India’s BioE3 strategy, coupled with China’s revamped food-enzyme regulations, has smoothed the path for market entry. Moreover, the region’s affordable production costs, a reservoir of skilled talent, and state-of-the-art infrastructure are luring global enzyme manufacturers. Collaborative research and development efforts, particularly under the Quad framework, bolster Asia-Pacific’s aspirations of becoming a dominant enzyme production hub. The region’s growing focus on biotechnology and government-backed initiatives to enhance enzyme production capacity further contribute to its rapid growth.

Europe, South America, the Middle East, and the Africa region are also making strides. Europe’s edge lies in its stringent safety protocols and a forward-thinking sustainability agenda, both of which enhance product quality and bolster consumer trust. Additionally, the region’s emphasis on green chemistry and eco-friendly enzyme applications aligns with its sustainability goals, driving further market expansion. Meanwhile, in South America, biotech ventures in Brazil and Argentina, buoyed by favorable trade agreements and bioeconomy initiatives, are driving growth in the food and agriculture sectors. The Middle East and Africa region is witnessing advancements, owing to healthcare enhancements and initiatives aimed at food security.

List of Companies Covered in this Report:

• International Flavors & Fragrances
• DSM-Firmenich AG
• Kerry Group plc
• BASF SE
• Associated British Foods plc
• Amano Enzyme
• Novozymes A/S
• Specialty Enzymes & Probiotics
• Suntaq International Limited
• Biocatalysts Ltd.
• Advanced Enzyme Technologies
• ENZIQUIM
• Nagase America LLC
• AST Enzymes
• Sunson Industry Group
• Enzyme Development Corporation
• Antozyme Biotech Pvt Ltd,
• NOOR ENZYMES (DWC) LLC
• Bioseutica BV
• Apex International

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Table of Contents

1 INTRODUCTION

1.1 Study Assumptions and Market Definition

1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Adoption of Eco-friendly Biocatalysts in Pharmaceutical Manufacturing

4.2.2 Government Support Drives Market Growth Through Policy and Funding

4.2.3 Advancement in Enzyme Engineering and Directed Evolution

4.2.4 Demand from Cosemetic and Dermatology Sectors for Enzymatic Peels

4.2.5 Surge in Demand for Enzymatic Wound Debridement Products

4.2.6 Growing Focus on Green Chemistry and Sustainable Industrial Process

4.3 Market Restraints

4.3.1 High Production Cost for Customised Enzymes

4.3.2 Short Shelf Life and Stability Challenges

4.3.3 Risk of Allergic Reaction and Immunogenicity in Enzyme Therapy

4.3.4 Ethical Concern in Use of Animal-Derived Enzymes

4.4 Supply Chain Analysis

4.5 Regulatory Outlook

4.6 Porter’s Five Forces

4.6.1 Threat of New Entrants

4.6.2 Bargaining Power of Buyers/Consumers

4.6.3 Bargaining Power of Suppliers

4.6.4 Threat of Substitute Products

4.6.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

5.1 By Source

5.1.1 Plant

5.1.2 Microbial

5.1.3 Animal

5.2 By Form

5.2.1 Liquid

5.2.2 Dry

5.3 By Type

5.3.1 Carbohydrases

5.3.2 Proteases

5.3.3 Lipases

5.3.4 Others

5.4 By Application

5.4.1 Food and Beverages

5.4.2 Pharmaceutical

5.4.3 Animal Feed

5.4.4 Others

5.5 By Geography

5.5.1 North America

5.5.1.1 United States

5.5.1.2 Canada

5.5.1.3 Mexico

5.5.1.4 Rest of North America

5.5.2 Europe

5.5.2.1 Germany

5.5.2.2 France

5.5.2.3 United Kingdom

5.5.2.4 Spain

5.5.2.5 Netherlands

5.5.2.6 Italy

5.5.2.7 Sweden

5.5.2.8 Poland

5.5.2.9 Belgium

5.5.2.10 Rest of Europe

5.5.3 Asia-Pacific

5.5.3.1 China

5.5.3.2 India

5.5.3.3 Japan

5.5.3.4 Australia

5.5.3.5 South Korea

5.5.3.6 Indonesia

5.5.3.7 Thailand

5.5.3.8 Singapore

5.5.3.9 Rest of Asia-Pacific

5.5.4 South America

5.5.4.1 Brazil

5.5.4.2 Argentina

5.5.4.3 Chile

5.5.4.4 Colombia

5.5.4.5 Peru

5.5.4.6 Rest of South America

5.5.5 Middle East and Africa

5.5.5.1 United Arab Emirates

5.5.5.2 South Africa

5.5.5.3 Nigeria

5.5.5.4 Saudi Arabia

5.5.5.5 Egypt

5.5.5.6 Morocco

5.5.5.7 Turkey

5.5.5.8 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

6.1 Market Concentration

6.2 Strategic Moves

6.3 Market Ranking Analysis

6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)

6.4.1 International Flavors & Fragrances

6.4.2 DSM-Firmenich AG

6.4.3 Kerry Group plc

6.4.4 BASF SE

6.4.5 Associated British Foods plc

6.4.6 Amano Enzyme

6.4.7 Novozymes A/S

6.4.8 Specialty Enzymes & Probiotics

6.4.9 Suntaq International Limited

6.4.10 Biocatalysts Ltd.

6.4.11 Advanced Enzyme Technologies

6.4.12 ENZIQUIM

6.4.13 Nagase America LLC

6.4.14 AST Enzymes

6.4.15 Sunson Industry Group

6.4.16 Enzyme Development Corporation

6.4.17 Antozyme Biotech Pvt Ltd,

6.4.18 NOOR ENZYMES (DWC) LLC

6.4.19 Bioseutica BV

6.4.20 Apex International

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

Mordor Intelligenceについて

Mordor Intelligence（モードーインテリジェンス）は2014年に設立されたインドの調査会社です。20の産業を対象に継続的に調査・出版が行っており、これまで世界の企業4000社以上に利用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみご利用が可能です。
    • 納品物：PDF（印刷不可・コピー＆ペースト不可）・Excel（印刷不可）
  • チームユーザライセンス
    • 同一企業内7名までご共有可能です。
    • 納品物：PDF（印刷可・コピー＆ペースト可）＋Excel （印刷可）
  • サイトライセンス
    • 同一企業・同一住所内人数無制限ご共有可能です。
    • 納品物：PDF（印刷可・コピー＆ペースト可）＋Excel （印刷可）
  • コーポレートライセンス
    • 一企業および関連企業内人数無制限でご共有可能です。
    • 納品物：PDF（印刷可・コピー＆ペースト可）＋Excel （印刷可）
• 納品形態
  • Eメール
• 納期
  • ご注文後3-4営業日

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ポンプ の市場シェア分析、業界動向と統計、成長予測 2025-2030年
• 洗濯洗剤 – 市場シェア分析、業界動向と統計、成長予測 2025-2030年
• 1,4-ブタンジオール – 市場シェア分析、業界動向と統計、成長予測 2025-2030年
• メモリスタの市場シェア分析、業界動向と統計、成長予測 2025-2030年
• 日本の電気自動車市場シェア分析、業界動向と統計、成長予測 2025-2030年

出版レポート一覧